Hypersensitivity  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00604578: Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma

Withdrawn
2
0
US
Pioglitazone Hydrochloride
National Heart, Lung, and Blood Institute (NHLBI)
Asthma, Airway Inflammation, Airflow Obstruction, Airway Hyperactivity
10/09
10/09
NCT00634036: Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics

Completed
2
23
US
pioglitazone, Actos, placebo
Fernando Holguin, Takeda, University of Vermont
Asthma
04/12
04/12
GLITZ, NCT00787644: Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)

Terminated
2
28
US
Pioglitazone, Placebo
University of Vermont, American Lung Association, University of Pittsburgh
Asthma, Obesity
06/13
12/13
NCT00994175: A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

Completed
2
15
US
Pioglitazone, Placebo
National Heart, Lung, and Blood Institute (NHLBI)
Severe, Refractory Asthma, Airway Inflammation, Airflow Obstruction
06/16
06/16
NCT02585765: Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI

Withdrawn
2
0
US
Pioglitazone, Placebo
James J. Peters Veterans Affairs Medical Center
Spinal Cord Injury, Pressure Ulcers
04/18
04/18

Download Options